» Articles » PMID: 32038284

A Brief History of Pacemaking

Overview
Journal Front Physiol
Date 2020 Feb 11
PMID 32038284
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac pacemaking is a most fundamental cardiac function, thoroughly investigated for decades with a multiscale approach at organ, tissue, cell and molecular levels, to clarify the basic mechanisms underlying generation and control of cardiac rhythm. Understanding the processes involved in pacemaker activity is of paramount importance for a basic physiological knowledge, but also as a way to reveal details of pathological dysfunctions useful in the perspective of a therapeutic approach. Among the mechanisms involved in pacemaking, the "funny" (I) current has properties most specifically fitting the requirements for generation and control of repetitive activity, and has consequently received the most attention in studies of the pacemaker function. Present knowledge of the basic mechanisms of pacemaking and the properties of funny channels has led to important developments of clinical relevance. These include: (1) the successful development of heart rate-reducing agents, such as ivabradine, able to control cardiac rhythm and useful in the treatment of diseases such as coronary artery disease, heart failure and tachyarrhythmias; (2) the understanding of the genetic basis of disorders of cardiac rhythm caused by HCN channelopathies; (3) the design of strategies to implement biological pacemakers based on transfer of HCN channels or of stem cell-derived pacemaker cells expressing I, with the ultimate goal to replace electronic devices. In this review, I will give a brief historical account of the discovery of the funny current and the development of the concept of I-based pacemaking, in the context of a wider, more complex model of cardiac rhythmic function.

Citing Articles

Role of HCN channels in the functions of basal ganglia and Parkinson's disease.

Qi Z, Yan Q, Fan X, Peng J, Zhu H, Jiang Y Cell Mol Life Sci. 2024; 81(1):135.

PMID: 38478096 PMC: 10937777. DOI: 10.1007/s00018-024-05163-w.


The enigmatic HCN channels: A cellular neurophysiology perspective.

Mishra P, Narayanan R Proteins. 2023; 93(1):72-92.

PMID: 37982354 PMC: 7616572. DOI: 10.1002/prot.26643.


An anchor-tether 'hindered' HCN1 inhibitor is antihyperalgesic in a rat spared nerve injury neuropathic pain model.

Tibbs G, Uprety R, Warren J, Beyer N, Joyce R, Ferrer M Br J Anaesth. 2023; 131(4):745-763.

PMID: 37567808 PMC: 10541997. DOI: 10.1016/j.bja.2023.06.067.


Palmitoylation regulates the magnitude of HCN4-mediated currents in mammalian cells.

Congreve S, Main A, Butler A, Gao X, Brown E, Du C Front Physiol. 2023; 14:1163339.

PMID: 37123274 PMC: 10133559. DOI: 10.3389/fphys.2023.1163339.


The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Wang M, Tu X Front Cardiovasc Med. 2022; 9:891399.

PMID: 35783865 PMC: 9240357. DOI: 10.3389/fcvm.2022.891399.


References
1.
DiFrancesco D, Tromba C . Inhibition of the hyperpolarization-activated current (if) induced by acetylcholine in rabbit sino-atrial node myocytes. J Physiol. 1988; 405:477-91. PMC: 1190986. DOI: 10.1113/jphysiol.1988.sp017343. View

2.
Barbuti A, Crespi A, Capilupo D, Mazzocchi N, Baruscotti M, DiFrancesco D . Molecular composition and functional properties of f-channels in murine embryonic stem cell-derived pacemaker cells. J Mol Cell Cardiol. 2009; 46(3):343-51. DOI: 10.1016/j.yjmcc.2008.12.001. View

3.
Gauss R, Seifert R, Kaupp U . Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature. 1998; 393(6685):583-7. DOI: 10.1038/31248. View

4.
Barbuti A, Baruscotti M, DiFrancesco D . The pacemaker current: from basics to the clinics. J Cardiovasc Electrophysiol. 2007; 18(3):342-7. DOI: 10.1111/j.1540-8167.2006.00736.x. View

5.
Noble D . Cardiac action and pacemaker potentials based on the Hodgkin-Huxley equations. Nature. 1960; 188:495-7. DOI: 10.1038/188495b0. View